Jo‐David Fine - Concepedia

Author

Jo‐David Fine

University of North Carolina at Chapel Hill

Also Known As

JO-DAVID FINE, Jo-David Fine, Jo‐David Fine

Publications

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Dystrophic Epidermolysis Bullosa Research Association of America University of Alabama at Birmingham University of Kentucky Vanderbilt University

About

Jo‐David Fine is an author at University of North Carolina at Chapel Hill specializing in medicine, dermatology, and dermatopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	2.8K
2	Cell Biology	2	2	484
3	Health Sciences	1	1	52
4	Public Health	1	1	14
5	Clinical Nutrition	1	1	52

Jo‐David Fine

Publications

Citations

H-Index

Page 1

	Year	Citations
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB Jo‐David Fine, Robin A.J. Eady, Eugene A. Bauer, Journal of the American Academy of Dermatology Inherited Epidermolysis BullosaDiagnosisPathologyClinical DermatologyDermatology	2008	921
Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006 Jo‐David Fine, Lorraine Johnson, Madeline Weiner, Journal of the American Academy of Dermatology Surgical OncologyMedicineCancer ManagementSurgical PathologyClinical Epidemiology	2008	448
Loss of Kindlin-1, a Human Homolog of the Caenorhabditis elegans Actin–Extracellular-Matrix Linker Protein UNC-112, Causes Kindler Syndrome Dawn H. Siegel, G H S Ashton, Homero Penagos, The American Journal of Human Genetics Causes Kindler SyndromeGenetic DisorderGeneticsProtein GeneticsMolecular Genetics	2003	341
Cause-Specific Risks of Childhood Death in Inherited Epidermolysis Bullosa Jo‐David Fine, Lorraine Johnson, Madeline Weiner, The Journal of Pediatrics Inherited Epidermolysis BullosaPathologyDermatologyDermatopathologyMedicine	2007	166
Increased Frequency of HLA-DR2 in Patients with Autoantibodies to Epidermolysis Bullosa Acquisita Antigen: Evidence that the Expression of Autoimmunity to Type VII Collagen Is HLA Class II Allele Associated W. Ray Gammon, Eugene R. Heise, William A. Burke, Journal of Investigative Dermatology HlaHistocompatibilityAutoimmune DiseaseHuman Leukocyte AntigenLupus	1988	158
Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa Yi-Zhen Ng, Céline Pourreyron, Julio C. Salas‐Alanís, Cancer Research Tumor BiologySkin DevelopmentType Vii CollagenCutaneous BiologyTumor Growth	2012	143
Eye involvement in inherited epidermolysis bullosa: Experience of the National Epidermolysis Bullosa Registry Jo‐David Fine, Lorraine Johnson, Madeline Weiner, American Journal of Ophthalmology Ocular DiseaseOphthalmologyInherited Epidermolysis BullosaPathologyGlaucoma	2004	112
GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: Results of a multicenter study O. M. V. Schofield, Jo‐David Fine, Patrick Verrando, Journal of the American Academy of Dermatology MedicineHistopathologyDiagnosisPathologyImmunology	1990	76
Genetic Basis of Dominantly Inherited Transient Bullous Dermolysis of the Newborn: A Splice Site Mutation in the Type VII Collagen Gene Angela M. Christiano, Jo‐David Fine, Jouni Uitto Journal of Investigative Dermatology Splice Site MutationCutaneous BiologyGeneticsGenetic DisorderDermatology	1997	71
Inherited epidermolysis bullosa and the risk of death from renal disease: Experience of the National Epidermolysis Bullosa Registry Jo‐David Fine, Lorraine Johnson, Madeline Weiner, American Journal of Kidney Diseases UrologyRenal DiseaseMedicineRenal PathologyPathology	2004	66

Page 1